Comments
Loading...

Regeneron Pharmaceuticals Inc Stock Guidance

REGNNASDAQ
$803.17
19.522.49%
At close: Feb 12, 4:00 PM EST
$797.57
13.921.78%
Pre-Market: 7:00 AM EST
Dividend: The dividend Ex-Date is in 3 days

Regeneron Pharmaceuticals Stock Guidance | NASDAQ:REGN | Benzinga

Regeneron Pharmaceuticals issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Get Alert
Regeneron Pharmaceuticals Inc (REGN) does not provide guidance data

FAQ

Q

What is the most recent guidance for Regeneron Pharmaceuticals (REGN)?

A

There have been no specific sales or earnings guidance reported for Regeneron Pharmaceuticals in recent months.